Genprex Inc.

NASDAQ: GNPX · Real-Time Price · USD
0.31
0.02 (7.79%)
At close: Jun 09, 2025, 3:59 PM

Genprex Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
n/a n/a n/a n/a
Cost of Revenue
n/a 15K 23.83M 22.53K
Gross Profit
n/a -15K -23.83M -22.53K
Operating Income
-21.17M -31.08M -23.83M -19.6M
Interest Income
63.57K 215.11K 90.1K 5.13K
Pretax Income
-21.39B -30.86M -23.74M -19.6M
Net Income
-21.39B -30.86M -29.46M -19.59M
Selling & General & Admin
10.63M 13.44M 12.3M 10.97M
Research & Development
10.54M 17.62M 11.51M 8.61M
Other Expenses
n/a n/a 25.57K 22.53K
Operating Expenses
21.17M 31.06M 23.83M 19.6M
Interest Expense
n/a n/a n/a n/a
Selling & Marketing Expenses
-10.62B n/a n/a n/a
Cost & Expenses
-21.17M 31.08M 23.83M 19.6M
Income Tax Expense
n/a n/a 5.72M -5.13K
Shares Outstanding (Basic)
4.01M 1.37M 1.2M 1.18M
Shares Outstanding (Diluted)
4.01M 1.37M 1.2M 1.18M
EPS (Basic)
-5.34K -22.58 -24.59 -16.64
EPS (Diluted)
-5.34K -22.56 -24.58 -16.64
EBITDA
-21.1M -31.06M -23.81M -20.65M
EBIT
n/a -31.08M -23.83M -20.66M
Depreciation & Amortization
n/a 15K 25.57K 22.53K